Mountain View, Calif.,
Dec. 1, 2016 /PRNewswire/
-- Omnicell, Inc., (NASDAQ: OMCL) a leading provider of
medication and supply management solutions and adherence tools for
healthcare systems and pharmacies, today revealed the broad range
of products for acute and non-acute care it will feature at this
year's American Society of Health-System Pharmacists 2016
Midyear Meeting, to be held in Las
Vegas from December 5-7.
In addition to Omnicell's 2016 Best in KLAS automated medication
dispensing cabinets, new solutions to be displayed include:
- Performance Center, a unique software and services
offering designed to manage drug costs and waste and improve
pharmacy efficiency
- Robotic IV Insourcing Solution™ (RIIS), which offers
pharmacies a comprehensive, turnkey approach to insourcing sterile
compounding
- Product enhancements offered through Omnicell's latest 21.0
software release, including Closed-Loop Dose
Accountability—which builds on Omnicell's interoperability package
with Epic—and improvements to Omnicell's unique
SinglePointe™ solution for managing patient-specific
medications
- New medication adherence solutions—software and hardware
tools to aid pharmacies in filling SureMed® by
Omnicell multi-medication blister cards to support increased
medication adherence
"With this year's acquisition of Aesynt, Omnicell has added new
distinct capabilities and is now uniquely positioned to offer
customers a complete set of innovative solutions that not only
ensures safer and higher quality care for patients, but also helps
increase medication adherence and reduce readmissions," said
Joe Lynch, vice president, Marketing
at Omnicell. "Our recent Best in KLAS award for Automated
Medication Dispensing Cabinets marks the 11th
consecutive year we have received top honors in this category,
signifying the impact that Omnicell products have on the way
medications and supplies are managed."
A broad range of solutions will be displayed in booth #420 for
the following areas:
Patient Care
On average, one medication error occurs per patient, per day in
U.S. hospitals.i With its latest 21.0 software release,
Omnicell has further improved safety, security and efficiency in
the medication process. New Closed-Loop Dose Accountability
automatically compares medications dispensed and/or wasted from the
Omnicell cabinet versus those documented as administered in the
Epic electronic health record (EHR), minimizing the risk of drug
diversion and saving nurse and pharmacy time. The 21.0 release also
enhances Omnicell's unique SinglePointe software for
managing patient-specific medications. SinglePointe now
automatically assigns locations based on medication type, providing
greater inventory control. For example, controlled substances and
high-value medications are assigned to metal locking lid drawers
for greater security.
Central Pharmacy
Controlled substances account for between 10 percent and 11
percent of all prescriptions written in the United States.ii Omnicell's
Controlled Substance Manager monitors medication
distribution anomalies and chain of custody in real time,
tightening inventory control, supporting quick resolution of
discrepancies, and providing comprehensive compliance documentation
for government agencies.
Omnicell's Central Pharmacy Manager software automates
manual processes to optimize inventory, floor space, and staff
time. The software works with medication carousels to consolidate
medication storage and streamline picking and stocking processes
and significantly reduces time spent on ordering and receiving
medications. By integrating with Omnicell's Satellite Pharmacy
Manager software, Central Pharmacy Manager provides inventory
visibility and automated replenishment for satellite pharmacies and
clinics, enabling smarter purchasing decisions.
Managing 90% or more of a hospital's daily medication
volume, ROBOT-Rx®, which was awarded
2016 KLAS Category Leader for Pharmacy Automation: Robots (Oral
Solid), automates medication storage, selection, return, and
restocking functions. It also reduces pharmacy labor and lowers
medication inventory.
Optimized Pharmacy Operations
A recent study by the American Hospital Association and the
Federation of American Hospitals showed that between 2013 and 2015
inpatient drug spending increased an average 23.4 percent annually,
and on a per admission basis, by 38.7 percent.iii
To help health systems tackle drug costs and other pharmacy
challenges, Omnicell recently introduced the Performance
Center. This unique software and services offering provides a
team of pharmacy and supply chain experts to constantly review
pharmacy data to reduce costs and improve enterprise-wide
management of one of the health system's largest cost centers.
Customers will experience benefits such as improved inventory
optimization, reduced expired medications, and compliance with 340B
and Controlled Substance Ordering System (CSOS) regulations.
Current Performance Center customers are already
attaining:
- 2.2% average annual medication spend savings
- 20.3% average reduction in inventory levels
- 77.8% increase in inventory turns.
Learn more about the Performance Center from Omnicell chairman,
president, CEO and founder Randall
Lipps at http://bcove.me/ak22pf23.
IV Compounding
Data shows that nearly 1 out of 10 IVs are not being prepared
within guidelines, which presents a serious risk to both hospitals
and their patients.iv Also, with IV/Injectables
constituting 80% of drug spend and 56% of pharmacy
costs, pharmacists are now searching for a better way
to both increase safety and decrease expenses.v
Omnicell's Robotic IV Insourcing Solution (RIIS) offers
pharmacies a comprehensive, turnkey approach to insourcing sterile
compounding. Advanced IV robotic technology, novel data services
and application support, and expertly trained pharmacy technician
staff provide hospitals with everything they need to bring safe,
cost-effective, sterile compounding in-house.
Analytics
According to recent statistics, more than 100,000 doctors,
nurses, technicians, and other health providers struggle with drug
abuse or addiction.vi Hospitals that use Omnicell
Analytics software can reduce the time needed to audit
clinician transactions at the automated dispensing cabinets, and
facilitate documentation of suspected diversion. Shortening the
time it takes to detect a diversion incident helps reduce risks to
both patients and institutions.
Surgical and Specialty Care
The results of a recently published prospective study found that
about 1 in 20 perioperative medication administrations and half of
all surgical procedures resulted in a medication error and/or
adverse drug event.vii In addition to securing
controlled substances, Omnicell's Anesthesia
Workstation—part of the Unity platform—manages and stores
medications securely in the OR and offers technology to help
address medication label errors. In addition, the unique breakaway
bar on the Anesthesia Workstation enables quick access to emergency
medications.
Non-Acute Care
The number of Americans affected by at least one chronic
condition requiring medication therapy is expected to increase to
157 million by 2020.viii To help this growing patient
population manage their conditions, outpatient pharmacists are
investing in adherence solutions, including medication therapy
management, medication synchronization, and adherence
packaging.
Omnicell offers a suite of products designed to increase patient
access to medication adherence solutions, such as its
SureMed multi-medication blister cards, to help patients
remember to take the right medication at the right time. To aid
pharmacies in filling the SureMed cards, Omnicell has introduced
Guided Packing software and a new semi-automated packaging
solution. Omnicell has also partnered with Medisafe—a mobile
health solution that works in conjunction with SureMed adherence
packaging and is currently in use within retail pharmacy
settings.
At the meeting, Omnicell is also highlighting new collaborative
efforts with other industry leaders to streamline pharmacy
workflow. First-level integration has been added to Performance
Center via a hyperlink with the following leading IV software
solutions:
- B. Braun Infusomat Space Infusion System/Large Volume Pumps and
DoseTrac Infusion Management Software
- Hospira/Pfizer MedNet safety software
- Baxter Sigma Spectrum Gateway, a key element of the 2016 KLAS
award winning Sigma Spectrum Infusion System.
About Omnicell
Since 1992, Omnicell (NASDAQ: OMCL) has been inspired
to create safer and more efficient ways to manage medications and
supplies across all care settings. As a leader in medication and
supply dispensing automation, central pharmacy automation, IV
robotics, analytics software, and medication adherence and
packaging systems, Omnicell is focused on improving care across the
entire healthcare continuum—from the acute care hospital setting,
to post-acute skilled nursing and long-term care facilities, to the
patient's home.
Over 4,000 customers worldwide use Omnicell®
automation and analytics solutions to increase operational
efficiency, reduce medication errors, deliver actionable
intelligence and improve patient safety. The recent acquisition of
Aesynt adds distinct capabilities, particularly in central pharmacy
and IV robotics, creating the broadest medication management
product portfolio in the industry.
The Omnicell SureMed® solution provides innovative
medication adherence packaging to help reduce costly hospital
readmissions. These medication adherence solutions are used by over
17,000 institutional and retail pharmacies in North America and the United Kingdom. These pharmacies are served
via Omnicell's sales channels and our solutions enable them to
maintain high accuracy and quality standards in medication
dispensing and administration while optimizing productivity and
controlling costs.
For more information about Omnicell, Inc. please
visit www.omnicell.com.
OMCL-G
Editor's Notes:
- All Omnicell news releases (financial, acquisitions, products,
technology etc.) are issued exclusively by PR Newswire and are
immediately thereafter posted on the company's external website,
omnicell.com.
- Omnicell, the Omnicell logo design, and SureMed are registered
trademarks of Omnicell, Inc.
- All other brand or product names may be trademarks or
registered trademarks of their respective companies.
i Institute of Medicine. Preventing medication
errors. Washington, DC: National
Academies Press; 2006.
ii
https://www.deadiversion.usdoj.gov/fed_regs/notices/2010/fr06294.htm
iii 'Trends in Hospital Inpatient Drug Costs: Issues and
Challenges,' NORC. October 2016.
iv Flynn EA, Pearson RE, Barker K. Observational study
of accuracy in compounding i.v. admixtures at five hospitals. Am J
Health-Syst Pharm. 1997;54(8):904-12
v Results from the 2013 ASHP National Survey: The
Current State of Pharmacy Practice in Hospitals presented at the
2013 ASHP Midyear Clinical Meeting; Aesynt analysis of pre-mixed,
frozen premixed, and add-a-vial systems, March 2014.
vi Eisler P. Doctors, medical staff on drugs put
patients at risk. USA Today.
April 15, 2014.
vii Nanji, K. C., Patel, A., Shaikh, S., Seger, D. L.,
& Bates, D. W. (2016). Evaluation of perioperative medicationT
errors and adverse drug events. Anesthesiology, 124, 25–34. - See
more at:
http://www.psqh.com/analysis/ismp-key-medication-errors-in-the-surgical-environment/#sthash.PMfbwriZ.dpuf
viii Script Your Future, November
2011.
http://www.scriptyourfuture.org/wp-content/themes/cons/m/release.pdf
Logo -
http://photos.prnewswire.com/prnh/20120731/SF48971LOGO-a
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/omnicell-showcases-expanded-portfolio-of-award-winning-medication-management-solutions-at-annual-ashp-midyear-meeting-300371295.html
SOURCE Omnicell, Inc.